Table 1.
Comparison of number of patients pre- and post-COVID-19.
|
Whole study period |
pre-COVID-19 |
March to June 2020 |
post-COVID-19* |
||
|---|---|---|---|---|---|
| (20 months) | (8 months) | (4 months) | (8 months) | ||
| Total patients | 5300 | 4266 | 333 | 701 | (16.4%) |
| Measles | 0 | 0 | 0 | 0 | (−) |
| Rubella | 0 | 0 | 0 | 0 | (−) |
| Varicella | 9 | 6 | 1 | 2 | (33.3%) |
| Mumps | 1 | 0 | 0 | 1 | (−) |
| Pertussis | 18 | 16 | 2 | 0 | (0.0%) |
| Influenza A | 271 | 269 | 2 | 0 | (0.0%) |
| Influenza B | 45 | 39 | 6 | 0 | (0.0%) |
| RSV | 804 | 795 | 6 | 3 | (0.4%) |
| hMPV | 210 | 201 | 9 | 0 | (0.0%) |
| Mycoplasma penumoniae | 164 | 158 | 4 | 2 | (1.3%) |
| Adenovirus (respiratory infection) | 88 | 46 | 14 | 28 | (60.9%) |
| LRTI | 2439 | 1984 | 121 | 334 | (16.8%) |
| Rotavirus gastroenteritis | 44 | 38 | 5 | 1 | (2.6%) |
| Norovirus gastroenteritis | 134 | 97 | 10 | 27 | (27.8%) |
| Adenovirus gastroenteritis | 48 | 37 | 6 | 5 | (13.5%) |
| Other gastroenteritis | 396 | 232 | 37 | 127 | (54.7%) |
| Aseptic meningitis | 17 | 14 | 2 | 1 | (7.1%) |
| Bacterial meningitis | 3 | 0 | 0 | 3 | (−) |
| Encephalitis/Encephalopathy | 27 | 22 | 3 | 2 | (9.1%) |
| Complex febrile seizure | 73 | 42 | 7 | 24 | (57.1%) |
| UTI | 239 | 109 | 40 | 90 | (82.6%) |
| KD | 270 | 161 | 58 | 51 | (31.7%) |
*Number in parentheses is the percentage of patients post-COVID-19 compared to pre-COVID-19.